FDA Announces Approval of New Drug to Treat Influenza

Oct 31, 2018 | Kimberly Sharpe-Scott

On October 24, the U.S. Food and Drug Administration (FDA) issued a news release announcing its approval of XOFLUZATM (baloxavir marboxil) for the treatment of acute uncomplicated influenza in patients 12 years of age and older who have been symptomatic for no more than 48 hours.

The FDA’s Commissioner, Scott Gottlieb, M.D., stated, “This is the first new antiviral flu treatment with a novel mechanism of action approved by the FDA in nearly 20 years. With thousands of people getting the flu every year, and many people becoming seriously ill, having safe and effective treatment alternatives is critical. This novel drug provides an important, additional treatment option.”

For additional information, access the FDA’s News Release: FDA approves new drug to treat influenza. For specific details regarding the approval of XOFLUZATM, access the FDA’s NDA Approval letter.


About Kimberly Sharpe-Scott

More posts by Kimberly Sharpe-Scott

Related Posts

I Stock 1182682774
  • Adverse Childhood Experiences (ACEs)
  • Behavioral Health
  • Community Health
  • Injury and Violence Prevention

Seeking LHD Participants for an Intersectional Data...

With support from the Centers for Disease Control and Prevention, NACCHO is...

Mar 28, 2024 | Camille Adams

Seeking LHD Participants for an Intersectional Data...

World TB Day 2024 1
  • ID Featured
  • Infectious Disease
  • Tuberculosis

Recognizing World TB Day 2024: The Role of Local Health...

LHDs across the nation actively work to eliminate TB through surveillance, case...

Mar 21, 2024 | Kimberly Nalley

Recognizing World TB Day 2024: The Role of Local Health...

I Stock 1318852282
  • COVID-19
  • Immunization
  • Infectious Disease
  • Influenza

Maternal and Child Vaccine Safety - Enhancing Vaccine...

After conducting a Rapid Community Assessment (RCA), in collaboration with the...

Mar 19, 2024 | Victoria Thompson, Clarissa Montes

Maternal and Child Vaccine Safety - Enhancing Vaccine...

Measles Blog 1
  • Tools & Resources
  • Community Health
  • ID Featured
  • Immunization

The Current Status of Measles in the US + Resources to...

This resource round-up aims to help local health departments and healthcare...

Mar 18, 2024 | Irene Halferty, Emma James, Victoria Thompson, Amy Maxson, Robin Mowson

The Current Status of Measles in the US + Resources to...

1

Building Community Resilience Through Maternal and Child...

NACCHO, with funding from the Centers for Disease Control and Prevention’s...

Mar 15, 2024 | Elana Filipos

Building Community Resilience Through Maternal and Child...

  • HIV, STI, & Viral Hepatitis

CDC Study Reveals Increase in Overdoses Associated with...

A recent CDC study demonstrates a need for LHDs and other local harm reduction...

Mar 14, 2024 | Kat Kelley, Anjana Rao, Grace Murtha

CDC Study Reveals Increase in Overdoses Associated with...

1

Bridging Maternal-Child Health (MCH), Infectious Disease...

Funded through the Center for Disease Control and Prevention’s (CDC) National...

Mar 12, 2024 | Elana Filipos

Bridging Maternal-Child Health (MCH), Infectious Disease...

Thumbnail youtube
  • Tools & Resources
  • Adverse Childhood Experiences (ACEs)

NACCHO Releases “Community Partnerships to Prevent...

The National Association of County and City Health Officials is pleased to...

Mar 12, 2024 | Camille Adams

NACCHO Releases “Community Partnerships to Prevent...

1
  • Maternal, Child, & Adolescent Health

NACCHO Provides Funding to Local Health Departments to...

The Maternal, Child, and Adolescent Health team has selected 14 new local...

Mar 11, 2024 | Ryanna Quazi

NACCHO Provides Funding to Local Health Departments to...

Back to Top